Left Ventricular Assistant Device in End Stage Heart Failure as A Step of Heart Transplantation Center: A Case Report

Document Type : Case Report


1 Cardiothoracic Surgery Department, Faculty of Medicine, Minia University, Egypt.

2 Madinah Cardiac Center, Adult Cardiac Surgery Department, Madinah, Saudi Arabia.

3 King Salman Heart Center, King Fahd Medical City, Adult Cardiac Surgery Department, Riyadh, Saudi Arabia.


With increasing prevalence of patients with advanced heart failure (AHF), increasing amount of readmission frequencies, duration of maximum medical therapy, and the 50% mortality during one-year, Left ventricular assist devices (LVAD) are considered to be an acceptable treatment option in these cases. Advanced newer‑generation of LVAD devices improves outcomes, and deceases morbidity . LVAD is considered as a bridging therapy in cases of decompensated HF which are scheduled for heart transplantation (HTx), or as destination therapy (DT) for cases either elder or with severe comorbid condition . LVAD is mechanical device that assists the pumping function of left ventricle (LV) by diverting blood into an external circulatory circuit connecting to the aorta. LVAD usually consists of (A) pump implanted to LV, (B) percutaneous driveline, and (C) externally controller and batteries .


  1. Ma WW, Suhitharan T, Shah SS, Kothandan H. Anesthesia for left ventricular assisted device insertion in a patient with multiple organ failure. Saudi Journal of Anaesthesia. 2021 Apr;15(2):210.
  2. Han JJ, Acker MA, Atluri P. Left ventricular assist devices: synergistic model between technology and medicine. Circulation. 2018 Dec 11;138(24):2841-51.
  3. Chair SY, Doris SF, Ng MT, Wang Q, Cheng HY, Wong EM, et al. Evolvement of left ventricular assist device: the implications on heart failure management. Journal of Geriatric Cardiology: JGC. 2016 Jul;13(5):425.
  4. McNamara N, Narroway H, Williams M, Brookes J, Farag J, Cistulli D, et al. Contemporary outcomes of continuous-flow left ventricular assist devices—A systematic review. Annals of cardiothoracic surgery. 2021 Mar;10(2):186.
  5. Han JJ, Acker MA, Atluri P. Left ventricular assist devices: synergistic model between technology and medicine. Circulation. 2018 Dec 11;138(24):2841-51.
  6. Zijderhand CF, Knol WG, Budde RP, van der Heiden CW, Veen KM, Sjatskig J, et al. Relapsing low-flow alarms due to suboptimal alignment of the left ventricular assist device inflow cannula. European Journal of Cardio-Thoracic Surgery. 2022 Oct;62(4):ezac415.
  7. Zhigalov K, Mashhour A, Szczechowicz M, Mkalaluh S, Baranov A, Easo J, et al. Long-Term Left Ventricular Assist Device (LVAD): A Rare Case of 10 Years’ Support and Follow-Up. The American Journal of Case Reports. 2019;20:1035.
  8. Coco VL, De Piero ME, Massimi G, Chiarini G, Raffa GM, Kowalewski M, et al. Right ventricular failure after left ventricular assist device implantation: a review of the literature. Journal of Thoracic Disease. 2021 Feb;13(2):1256.
  9. Etheridge JC, Cousins RS, Philpott JM. Massive intercostal hemorrhage after implantation of an intrapericardial ventricular assist device: A case report. Journal of Cardiac Surgery. 2021 Jan;36(1):381-3.
  10. Huenges K, Panholzer B, Cremer J, Haneya A. Left ventricular assist device implantation with concomitant aortic valve and ascending aortic replacement. Case Reports in Medicine. 2018 Jan 9;2018.